Device Trial Radar · NCT04107766
NOLA (NeuWave Observational Liver Ablation) Registry
Last checked: Nov 19, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,254
Actual
Start
Jan 15, 2020
Primary completion
Jun 18, 2025
Study completion Jun 18, 2025
Sponsor
- Lead sponsor
- Ethicon, Inc.Public (JNJ)
- Sponsor type
- Industry
- First posted
- Sep 27, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.
Conditions
- Cancer of the Liver
- Liver Cancer
- Neoplasms, Liver
Interventions
Microwave AblationDevice
Patients who meet the eligibility criteria will undergo microwave ablation (MWA) with the NEUWAVE Microwave Ablation System with or without Ablation Confirmation of at least one soft-tissue liver lesion, in accordance with the study site's standard-of-care (SOC) practices.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Patients Whose Ablation Resulted in Technical SuccessTime frame: Immediately post-ablation (Day 0)
- Number of Patients Whose Ablation Resulted in Technique EfficacyTime frame: Between 7 days and less than 3 months post-ablation
- Target Lesion Recurrence RateTime frame: Assessed at 6 months, 12 months, 18 months, 24 months, 30 months, 36 months, 42 months, 48 months, 54 months, and 60 months post-ablation.
Locations
28 sites in 8 countries. Site status is shown where the registry gives one.
Loma Linda University Medical Center
Loma Linda, California
Cedars Sinai Medical Center
Los Angeles, California
David Geffen School of Medicine at UCLA
Los Angeles, California
25 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.